BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Lexington Hires Medical Device Reimbursement Experts

  Lexington Biosciences, a development-stage medical device company, is pleased to announce entry into a strategic business relationship with a San Francisco arm of Navigant Consulting Inc., formerly Quorum Consulting.

  December 7, 2017

   · 

  4 min read
• Pharm Country

  iCAD Announces Study Demonstrating Economic and Health Benefits of Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer Treatment

  The analysis demonstrated that IORT could result in direct cost savings for the U.S. healthcare system of more than $630 million over the lifetime of patients diagnosed annually with early-stage breast cancer.

  December 7, 2017

   · 

  6 min read
• Report on Transactions With ALK-Abelló A/S B-Shares and Associated Securities by Managerial Staff

  ALK-Abelló is reporting the following transactions.

  December 7, 2017

   · 

  1 min read
• BioCapital

  India Globalization Capital Launches New Corporate Websites Highlighting Canna-Pharmaceutical Compound Portfolio

  The two new websites will detail the Company’s cannabinoid pipeline for the indications of pain, seizures, eating disorders and Alzheimer’s.

  December 7, 2017

   · 

  3 min read
• Biotech Bay

  Iovance Biotherapeutics to Webcast Analyst Day on Wednesday, December 13, 2017

  The event will highlight Iovance’s lead clinical programs.

  December 7, 2017

   · 

  1 min read
• Business

  Generex Announces Collaboration With Shenzhen BioScien Pharmaceuticals to Develop and Commercialize the AE37 Immunotherapeutic Vaccine for the Treatment of Prostate Cancer in China

  Shenzhen BioScien will pay Generex a non-refundable, up-front license fee of $700,000 USD.

  December 7, 2017

   · 

  4 min read
• Pluristem to Present Data on PLX-R18 in Treatment of Acute Radiation Syndrome at ASH’s Annual Meeting

  The results of the study will be presented during Program Session 506: Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells.

  December 7, 2017

   · 

  5 min read
• BioCapital

  Lonza to Showcase its Latest Solutions for Enhanced QC Testing and Transfection at SLAS2018

  At Booth 534 Lonza will showcase how its automated QC testing solutions and Nucleofector Devices can increase efficiency and throughput in the drug development process.

  December 7, 2017

   · 

  4 min read
• Bio NC

  G1 Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

  The inducement grant to Mr. Phillips consisted of an option to purchase up to 150,000 shares of common stock.

  December 7, 2017

   · 

  3 min read
• Business

  Regentys Appoints Dr. Steven D. Wexner Chief Medical Officer

  Dr. Wexner has been a member of the Regentys Medical Advisory Board since January 2014.

  December 7, 2017

   · 

  4 min read